Pharmacological treatment of social anxiety disorder: a meta-analysis (Q34219988)

31 July 2017

0 references

Pharmacological treatment of social anxiety disorder: a meta-analysis (English)

1 reference

31 July 2017

0 references

1 reference

social anxiety disorder

1 reference

Carlos Blanco

1

0 references

author name string

Franklin R Schneier

2

1 reference

31 July 2017

Andrew Schmidt

3

1 reference

31 July 2017

Carmen-Rosa Blanco-Jerez

4

1 reference

31 July 2017

Randall D Marshall

5

1 reference

31 July 2017

Arturo Sánchez-Lacay

6

1 reference

31 July 2017

Michael R Liebowitz

7

1 reference

31 July 2017

1 January 2003

1 reference

31 July 2017

Depression and Anxiety

1 reference

31 July 2017

18

1 reference

31 July 2017

29-40

1 reference

31 July 2017

1

1 reference

Pharmacotherapy of social anxiety disorder

31 July 2017

1 reference

Discontinuation of clonazepam in the treatment of social phobia.

21 January 2018

1 reference

Meta-analysis in clinical trials

21 January 2018

1 reference

Incorporating variations in the quality of individual randomized trials into meta-analysis.

21 January 2018

1 reference

Psychological and pharmacological treatments of social phobia: a meta-analysis

21 January 2018

1 reference

Psychometric properties of the Liebowitz Social Anxiety Scale.

21 January 2018

1 reference

Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome

21 January 2018

1 reference

Treatment of social phobia with gabapentin: a placebo-controlled study

21 January 2018

1 reference

Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis

21 January 2018

1 reference

Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults

21 January 2018

1 reference

Disability and quality of life in social phobia: epidemiologic findings

21 January 2018

1 reference

Social phobia symptoms, subtypes, and severity: findings from a community survey

21 January 2018

1 reference

Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study

21 January 2018

1 reference

Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor

21 January 2018

1 reference

Paroxetine in social anxiety disorder: a randomized placebo-controlled study

21 January 2018

1 reference

7 January 2021

Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group

1 reference

7 January 2021

Treatment of social phobia with clonazepam and placebo.

1 reference

7 January 2021

Recent developments in the psychopharmacology of social phobia

1 reference

7 January 2021

Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.

1 reference

7 January 2021

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

1 reference

7 January 2021

Cognitive-Behavioral and Pharmacological Treatment for Social Phobia: A Meta-Analysis

1 reference

7 January 2021

THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS

1 reference

7 January 2021

Social anxiety disorder in review: two decades of progress

1 reference

7 January 2021

Antidepressant treatment of depression: a metaanalysis

1 reference

7 January 2021

Sertraline for social phobia: a double-blind, placebo-controlled crossover study

1 reference

7 January 2021

1 reference

7 January 2021

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

1 reference

7 January 2021

Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study

1 reference

7 January 2021

Moclobemide in social phobia: a controlled dose-response trial

1 reference

7 January 2021

Moclobemide in the treatment of social phobia

1 reference

7 January 2021

Implications of the severity of social phobia

1 reference

7 January 2021

Placebo-controlled trial of moclobemide in social phobia

1 reference

7 January 2021

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

1 reference

7 January 2021

The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): a meta-analysis of randomized controlled trials.

1 reference

7 January 2021

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

1 reference

7 January 2021

Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study

1 reference

7 January 2021

Pharmacotherapy of Social Phobia

1 reference

7 January 2021

Issues in the transportability of treatment: the case of anxiety disorders in youths

1 reference

7 January 2021

Social phobia: a comparison of behavior therapy and atenolol

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.10096

1 reference

31 July 2017

1 reference